The global market for infection prevention and control (IPC) is witnessing a robust increase, driven by various contributing factors. The uptick in chronic diseases, an escalation in surgical procedures demanding stringent infection prevention guidelines, the proliferation of hospital-acquired infections, and amplified government initiatives advocating for elevated infection prevention standards are some of these factors. Additionally, advancements in product development, surge in product introductions, along with the expansion of the healthcare sector, augment market growth.
DelveInsight’s Infection Prevention and Control Market Insight report furnishes detailed analysis on current and forecast market trends, individual market shares of leading IPC companies, market drivers, obstacles, trends, and the leading IPC firms in the market. DelveInsight estimates predict North America’s superiority in the global IPC market during the projected period. With leading IPC companies like 3M, Fortive, Medivators Inc., Getinge AB, and others operating in this market, growth is imminent. Numerous product launches and strategic acquisitions have taken place in recent years, fortifying the market’s strength. For instance, Getinge’s acquisition of Ultra Clean Systems Inc., a leading US manufacturer of ultrasonic cleaning technologies, and the launch of Nanosonics AuditPro, an innovative infection prevention digital product platform, are notable examples.
Infection prevention and control critically impacts healthcare systems globally. It adopts a multi-faceted strategy incorporating stringent hygiene practices, robust surveillance systems, and adherence to evidence-based protocols to safeguard both patients and healthcare workers from infectious diseases. The disciplined practice of IPC helps in checking the transmission of pathogens in healthcare facilities and plays a pivotal role in containing outbreaks within communities. IPC extends its significance beyond healthcare settings, infiltrating various sectors such as food handling, hospitality, and community interactions.
In-depth market insights indicate North America’s dominance in the IPC market. Factors contributing to this dominance include the rising prevalence of chronic diseases, a surge in hospital-acquired infections, increased awareness about IPC practices, and an aging population. The region is expected to see a substantial growth from 2024 to 2030, supported by increased healthcare spending, advancements in healthcare standards, the presence of outsourcing organizations, and consistent strategic collaborations.
The dynamics of the infection prevention and control market are shaped by advancements in technology, regulatory changes, increased awareness on healthcare-associated infections, and the emergence of infectious diseases. The global COVID-19 pandemic has significantly impacted the IPC market, leading to a spike in demand for products and services aimed at alleviating the virus’s spread, thereby expanding the IPC market. Emerging technologies like UV-C disinfection systems, contactless technologies, and personal protective equipment have seen an accelerated adoption rate due to this health crisis.
The IPC market is consequently poised for steady growth, propelled by emerging disease threats and the ongoing need to bolster global healthcare infrastructure.
Source: https://finance.yahoo.com/news/global-infection-prevention-control-market-093000970.html